[1]
|
Bajaj, T. and Aboeed, A. (2021, May 9) Chest Wall Tumors. In: StatPearls, StatPearls Publishing, Treasure Is-land.
|
[2]
|
Harati, K., Kolbenschlag, J., Behr, B., Goertz, O., Hirsch, T., Kapalschinski, N., et al. (2015) Thoracic Wall Reconstruction after Tumor Resection. Frontiers in Oncology, 5, Article No. 247. https://doi.org/10.3389/fonc.2015.00247
|
[3]
|
Marina, N.M., Smeland, S., Bielack, S.S., Bernstein, M., Jovic, G., Krailo, M.D., et al. (2016) Comparison of MAPIE versus MAP in Patients with a Poor Response to Preoperative Chem-otherapy for Newly Diagnosed High-Grade Osteosarcoma (EURAMOS-1): An Open-Label, International, Randomised Controlled Trial. The Lancet Oncology, 17, 1396-1408. https://doi.org/10.1016/S1470-2045(16)30214-5
|
[4]
|
Choi, H.J. and Jae, R.Y. (2021) The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities. Advances In Anatomic Pathology, 28, 44-58. https://doi.org/10.1097/PAP.0000000000000284
|
[5]
|
Choi, H.J. and Jae, R.Y. (2021) The 2020 WHO Classification of Tumors of Bone: An Updated Review. Advances in Anatomic Pa-thology, 45, 119-138. https://doi.org/10.1097/PAP.0000000000000293
|
[6]
|
Cetinkaya, O.A., Celik, S.U., Kalem, M., Basarir, K., Koksoy, C. and Yildiz, H.Y. (2019) Clinical Characteristics and Surgical Outcomes of Limb-Sparing Surgery with Vascular Reconstruction for Soft Tissue Sarcomas. Annals of Vascular Surgery, 56, 73-80. https://doi.org/10.1016/j.avsg.2018.09.018
|
[7]
|
Wu, G., Yang, H. and Li, X. (2019) Feeding Arteries and Arterio-venous Shunt for Discrimination of Soft Tissue Tumors. Medicine, 98, Article No. e16346. https://doi.org/10.1097/MD.0000000000016346
|
[8]
|
Bourcier, K., Le Cesne, A., Tselikas, L., Adam, J., Mir, O., Honore, C., et al. (2019) Basic Knowledge in Soft Tissue Sarcoma. CardioVascular and Interventional Radiology, 42, 1255-1261. https://doi.org/10.1007/s00270-019-02259-w
|
[9]
|
茅乃权, 左传田, 周元明, 祝家兴, 黄鼎铭, 谢彤, 等. 胸壁肿瘤的外科治疗[J]. 中国胸心血管外科临床杂志, 2005, 12(4): 299-300.
|
[10]
|
Kozak, K., Łochowski, M.P., Białas, A., Rusinek, M. and Kozak, J. (2016) Surgical Treatment of Tumours of the Sternum—10 Years’ Experi-ence. Kardiochirurgia i Torakochirurgia Polska, 13, 213-216.
https://doi.org/10.5114/kitp.2016.62608
|
[11]
|
中国医师协会胸外科医师分会. 胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版) [J]. 中国胸心血管外科临床杂志, 2019, 26(1): 1-7.
|
[12]
|
Scarnecchia, E., Liparulo, V., Capozzi, R., Ceccarelli, S., Puma, F. and Vannucci, J. (2018) Chest Wall Resection and Reconstruction for Tumors: Analysis of Oncological and Functional Outcome. Journal of Thoracic Disease, 10, S1855-S186. https://doi.org/10.21037/jtd.2018.05.191
|
[13]
|
曹子昂, 郑家豪, 钱晓哲, 孙志勇, 张冬蕾. 自体材料和人工仿生材料修复大块胸壁缺损的临床比较[J]. 中华胸心血管外科杂志, 2015, 31(1): 44-45.
|
[14]
|
杨振华, 胡天军, 沈海波, 周银杰. 自体肋骨移植在巨大胸壁缺损重建中的应用[J]. 华中科技大学学报(医学版), 2019, 48(4): 474-476.
|
[15]
|
Drinnon, K.D., Sherali, S., Cox, C.T. and MacKay, B.J. (2020) Sternal Tumor Resection and Reconstruc-tion Using Iliac Crest Autograft. Plastic and Reconstructive Surgery - Global Open, 8, Article No. e3002.
https://doi.org/10.1097/GOX.0000000000003002
|
[16]
|
贾挺挺, 陈思琪, 郭敏杰. 聚对二氧环己酮的应用研究进展[J]. 化学研究与应用, 2018, 30(11): 1751-1756.
|
[17]
|
杜荣旭, 俞楠泽, 龙笑, 黄久佐, 王晨羽, 王晓军. 胸壁重建材料的应用进展[J]. 中国医学科学院学报, 2018, 40(2): 289-293.
|
[18]
|
王强, 孙照军, 赵娜. 涤纶布修补胸壁肿瘤切除后巨大胸壁缺损的临床研究[J]. 中国医药指南, 2018, 16(1): 113.
|
[19]
|
Tamburini, N., Grossi, W., Sanna, S., Campisi, A., Londero, F., Maniscalco, P., et al. (2019) Chest Wall Reconstruction Using a New Titanium Mesh: A Multicenters Experience. Journal of Thoracic Disease, 11, 3459-3466.
https://doi.org/10.21037/jtd.2019.07.74
|
[20]
|
Wu, Y., Chen, N., Xu, Z., Zhang, X., Liu, L., Wu, C., et al. (2018) Application of 3D Printing Technology to Thoracic Wall Tumor Resection and Thoracic Wall Reconstruction. Journal of Thoracic Disease, 10, 6880-6890.
https://doi.org/10.21037/jtd.2018.11.109
|
[21]
|
Javier, A. and Itzell, P.M. (2016) Dynamic 3D Printed Titanium Copy Prosthesis: A Novel Design for Large Chest Wall Resection and Reconstruction. Journal of Thoracic Disease, 8, E385-E389.
https://doi.org/10.21037/jtd.2016.03.94
|
[22]
|
Khalil, H.H., Kalkat, M., Malahias, M.N., Rhobaye, S., Ashour, T., Djearaman, M.G., et al. (2018) Chest Wall Reconstruction with Porcine Acellular Dermal Matrix (Strattice) and Autolo-gous Tissue Transfer for High Risk Patients with Chest Wall Tumors. Plastic and Reconstructive Surgery - Global Open, 6, Article No. e1703.
https://doi.org/10.1097/GOX.0000000000001703
|
[23]
|
王少强, 陈静, 魏松洋, 郑庆杰. 胸壁肿瘤切除后胸壁缺损的修复[J]. 组织工程与重建外科杂志, 2019, 15(4): 237-240.
|
[24]
|
Billington, A., Dayicioglu, D., Smith, P. and Kiluk, J. (2019) Review of Procedures for Reconstruction of Soft Tissue Chest Wall Defects Following Advanced Breast Malignancies. Cancer Control, 26, 1-7.
https://doi.org/10.1177/1073274819827284
|
[25]
|
Gronchi, A., Palmerini, E., Quagliuolo, V., Martin Broto, J., Lopez Pousa, A., Grignani, G., et al. (2020) Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Re-sults of a Randomized Trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. Journal of Clinical Oncology, 38, 2178-2186.
https://doi.org/10.1200/JCO.19.03289
|
[26]
|
Graham, D.S., Van Dams, R., Jackson, N.J., Onyshchenko, M., Eck-ardt, M.A., DiPardo, B.J., et al. (2020) Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma. Cancers, 12, Article No. 2389. https://doi.org/10.3390/cancers12092389
|
[27]
|
Tap William, D., Zsuzsanna, P., Van Tine, B.A., Attia, S., Ganjoo, K.N., Jones, R.L., et al. (2017) Doxorubicin plus Evofosfamide versus Doxorubicin Alone in Locally Advanced, Unresectable or Metastatic Soft-Tissue Sarcoma (TH CR-406/SARC021): An International, Multicentre, Open-Label, Randomised Phase 3 Trial. The Lancet Oncology, 18, 1089-1103. https://doi.org/10.1016/S1470-2045(17)30381-9
|
[28]
|
Sun, X., Chen, Y., Yu, H., Machan, J.T., Al-ladin, A., Ramirez, J., et al. (2019) Anti-MiRNA Oligonucleotide Therapy for Chondrosarcoma. Molecular Cancer Therapeutics, 18, 2021-2029.
https://doi.org/10.1158/1535-7163.MCT-18-1020
|
[29]
|
Lilienthal, I. and Herold, N. (2020) Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. International Journal of Molecular Sciences, 21, Article No. 6885. https://doi.org/10.3390/ijms21186885
|
[30]
|
Cesne, A.L., Bauer, S., Demetri, G.D., Han, G., Dezzani, L., Ahmad, Q., et al. (2019) Safety and Efficacy of Pazopanib in Advanced Soft Tissue Sarcoma: PALETTE (EORTC 62072) Sub-group Analyses. BMC Cancer, 19, Article No. 794. https://doi.org/10.1186/s12885-019-5988-3
|
[31]
|
Chi, Y., Fang, Z., Hong, X., Yao, Y., Sun, P., Wang, G., et al. (2018) Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis In-hibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. Clinical Cancer Research, 24, 5233-5238. https://doi.org/10.1158/1078-0432.CCR-17-3766
|
[32]
|
Italiano, A., Soria, J.C., Toulmonde, M., Michot, J.M., Lucchesi, C., Varga, A., et al. (2018) Tazemetostat, an EZH2 Inhibitor, in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Advanced Solid Tumours: A First-In-Human, Open-Label, Phase 1 Study. The Lancet Oncology, 19, 649-659. https://doi.org/10.1016/S1470-2045(18)30145-1
|
[33]
|
Czarnecka, A.M., Synoradzki, K., Firlej, W., Bart-nik, E., Sobczuk, P., Fiedorowicz, M., et al. (2020) Molecular Biology of Osteosarcoma. Cancers, 12, Article No. 2130. https://doi.org/10.3390/cancers12082130
|
[34]
|
Ribeiro, C.J., Rodrigues, C.M., Moreira, R. and Santos, M.M.M. (2016) Chemical Variations on the P53 Reactivation Theme. Pharmaceuticals, 9, Article No. 25. https://doi.org/10.3390/ph9020025
|
[35]
|
Tian, Z., Niu, X. and Yao, W. (2020) Receptor Tyrosine Kinases in Oste-osarcoma Treatment: Which Is the Key Target? Frontiers in Oncology, 10, Article No. 1642. https://doi.org/10.3389/fonc.2020.01642
|
[36]
|
Paoluzzi, L., Cacavio, A., Ghesani, M., Karambelkar, A., Rapkiewicz, A., Weber, J., et al. (2016) Response to Anti-PD1 Therapy with Nivolumab in Metastatic Sarcomas. Clinical Sarcoma Research, 6, Article No. 24.
https://doi.org/10.1186/s13569-016-0064-0
|
[37]
|
Martin-Broto, J., Hindi, N., Grignani, G., Martinez-Trufero, J., Redondo, A., Valverde, C., et al. (2020) Nivolumab and Sunitinib Combination in Advanced Soft Tissue Sarcomas: A Multicenter, Single-Arm, Phase Ib/II Trial. Journal for ImmunoTherapy of Cancer, 8, Article ID: e001561. https://doi.org/10.1136/jitc-2020-001561
|
[38]
|
Liu, W., Jiang, Q. and Zhou, Y. (2018) Advances of Systemic Treatment for Adult Soft-Tissue Sarcoma. Chinese Clinical Oncology, 7, Article No. 42. https://doi.org/10.21037/cco.2018.08.02
|
[39]
|
Toulmonde, M., Penel, N., Adam, J., Chevreau, C., Blay, J.Y., Le Cesne, A., et al. (2018) Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial. JAMA Oncology, 4, 93-97.
https://doi.org/10.1001/jamaoncol.2017.1617
|
[40]
|
Tawbi, H.A.H., Burgess, M., Crowley, J., Van Tine, B.A., Hu, J., Schuetze, S., et al. (2016) Safety and Efficacy of PD-1 Blockade Using Pembrolizumab in Patients with Advanced Soft Tissue (STS) and Bone Sarcomas (BS): Results of SARC028—A Multicenter Phase II Study. Journal of Clinical Oncology, 34, 11006.
https://doi.org/10.1200/JCO.2016.34.15_suppl.11006
|
[41]
|
Tawbi, H.A., Burgess, M., Bolejack, V., Van Tine, B.A., Schuetze, S., Hu, J., et al. (2017) Pembrolizumab in Advanced Soft-Tissue Sarcoma and Bone Sarcoma (SARC028): A Multicentre, Two-Cohort, Single-Arm, Open-Label, Phase 2 Trial. The Lancet Oncology, 18, 1493-1501. https://doi.org/10.1016/S1470-2045(17)30624-1
|
[42]
|
von Mehren, M., Randall, R.L., Benjamin, R.S., Boles, S., Bui, M.M., Ganjoo, K.N., et al. (2018) Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer, 6, 536-563. https://doi.org/10.6004/jnccn.2018.0025
|
[43]
|
Furuhira, T. (2015) Intensity Modulated Radiotherapy. Nihon Jibi-inkoka Gakkai Kaiho, 118, 1380-1384. (In Japanese).
|
[44]
|
Hoefkens, F., Dehandschutter, C., Somville, J., Meijnders, P. and Van Gestel, D. (2016) Soft Tissue Sarcoma of the Extremities: Pending Questions on Surgery and Radiotherapy. Radiation Oncology, 11, Article No. 136.
https://doi.org/10.3950/jibiinkoka.118.1380
|
[45]
|
Choi, S.H., Yoon, H.I., Kim, S.H., Kim, S.K., Shin, K.-H. and Suh, C.-O. (2018) Optimal Radiotherapy Strategy for Primary or Recurrent Fibromatosis and Long-Term Results. PLoS ONE, 13, Article No. e0198134.
https://doi.org/10.1186/s13014-016-0668-9
|
[46]
|
Gao, Z., Lu, T., Song, H., Gao, Z., Ren, F., Ouyang, P., et al. (2019) Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma. Medical Science Mon-itor, 25, 8952-8967.
https://doi.org/10.1371/journal.pone.0198134
|
[47]
|
中华医学会放射肿瘤学分会, 中国医师学会放射治疗专业委员会, 中国抗癌协会肿瘤微创治疗分会粒子治疗学组, 等. CT引导放射性125I粒子组织间永久植入治疗肿瘤专家共识[J]. 中华医学杂志, 2017, 97(15): 1132-1139.
|
[48]
|
Jiang, W., Chen, Y., Ji, Z., Jiang, Y., Qiu, B., Sun, H., et al. (2021) The Accuracy and Dosimetric Analysis of 3D-Printing Non-Coplanar Template-Assisted Iodine-125 Seed Im-plantation for Recurrent Chest Wall Cancer. Journal of Contemporary Brachytherapy, 13, 273-279. https://doi.org/10.12659/MSM.917959
|